FEATURED/ARCHIVES (29/03/24)
×
Artificial Intelligence Framework Identifies Candidate Targets for Drug Repurposing in Alzheimer’s Disease · January 2022
Articles
Alzheimer’s Research and Therapy
×
Association of 5a-Reductase Inhibitors with Dementia, Depression, and Suicide · December 2022
Articles
JAMA Network Open
×
Pharmacologic Management of Neuropsychiatric Symptoms of Alzheimer Disease · October 2007
Articles
Canadian Journal of Psychiatry
×
Deprescribing Antipsychotics for Behavioural and Psychological Symptoms of Dementia and Insomnia: Evidence-Based Clinical Practice Guideline · January 2018
Articles
Canadian Family Physician
×
The Role of the Primary Care Physician in the Management of Parkinson’s Disease Dementia (Dementia in Parkinson’s Disease: Everything you Need to Know) · October 2021
Publications (Chapters)
IntechOpen Books
×
Evaluating the Cognitive Effects of Donepezil 23 Mg/d in Moderate and Severe Alzheimer’s Disease: Analysis of Effects of Baseline Features on Treatment Response · June 2013
Articles
BMC Geriatrics
×
Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial · June 2003
Articles
JAMA Neurology
×
Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled, Confirmatory Phase III Trial · February 2015
Articles
Alzheimer’s Research and Therapy
×
Pharmacological Treatment of Frontal Lobe Dementia: Recent Advances (Meetings-Events) · August 2015
Multimedia (Lectures-Conferences)
European College of Neuropsychopharmacology
×
Frontotemporal Dementia and Pharmacologic Interventions · December 2010
Articles
Journal of Neuropsychiatry and Clinical Neurosciences
×
Guidelines on Antipsychotics for Dementia: Are We Losing Our Minds? · February 2009
Articles
BJPsych Bulletin
×
QT Interval Prolongation and Torsades De Pointes with Donepezil, Rivastigmine and Galantamine · August 2020
Articles
Therapeutic Advances in Drug Safety
×
Clinical Trials of New Drugs for Alzheimer Disease · January 2020
Articles
Journal of Biomedical Science
×
A Real-World Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-Diagnosed Alzheimer’s Disease Patients · May 2017
Articles
Neurology and Therapy
×
Nilvadipine in Mild to Moderate Alzheimer Disease: A Randomised Controlled Trial · September 2018
Articles
PLOS Medicine
×
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis · September 2021
Articles
Journal of Alzheimer’s Disease Reports